See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Feb. 13, 2004

Emphysema Diabetes - Type 2 Hepatitis

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Emphysema

A research study to assess safety and efficacy of the emphasys endobronchial valve (EBV) with pulmonary rehabilitation compared to optimal medical management with pulmonary rehabilitation. Volunteers ages 40-75 who have heterogeneous emphysema may be eligible. Research sites located throughout the world.

More Information

Please see http://www.centerwatch.com/patient/studies/cat59.html.

-----

Diabetes - Type 2

A research study of an investigational medication for hypertensive patients with type 2 diabetes. Volunteers between 18 and 75 who have the ability to go off all anti-hypertensive medications and who have been diagnosed with type 2 diabetes may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Hepatitis

A research study of an investigational medication for the treatment of hepatitis C in patients with thalassemia. Volunteers 18 or older who have thalassemia and are hepatitis C positive as shown by a blood test may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat79.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News
undefined
undefinedundefined